Metraipolis › archive › dc_953cfde0b291

Nanomedicine for targeting cancer-associated fibroblasts in cancer therapy — Europe PMC PMID:41355964

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41355964
DOI
10.7150/thno.120283
License (as archived)
solo-consultazione
Archived
2026-11-07T03:55:55.558Z
SHA-256 of the archived text
a1f75cba023936d49ed47137073d18f67c1a5c7bcf60a723b3dbd03b2391f687
Stable URL of this page
https://metraipolis.com/documento/dc_953cfde0b291

How to cite

Nanomedicine for targeting cancer-associated fibroblasts in cancer therapy — Europe PMC PMID:41355964 — Europe PMC (en), https://europepmc.org/article/MED/41355964 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_953cfde0b291 (Metraipolis archive dc_953cfde0b291, sha256 a1f75cba023936d49ed47137073d18f67c1a5c7bcf60a723b3dbd03b2391f687)
BibTeX
@misc{dc953cfde0b291,
  title = {Nanomedicine for targeting cancer-associated fibroblasts in cancer therapy — Europe PMC PMID:41355964},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41355964},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_953cfde0b291; sha256 a1f75cba023936d49ed47137073d18f67c1a5c7bcf60a723b3dbd03b2391f687},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41355964. Agents can read the archived copy with the MCP tool read_document.